Research Presentation- Relearn Pain: Digital PRT and EAET for Chronic primary Pain. First Clinical Outcomes of the HELP Program by Antje Kallweit, MD. Workshop Summary:
This talk focuses on how mind–body approaches to chronic pain can move from the margins into mainstream healthcare. It explores what is required to translate neuroscience-informed, emotionally effective pain therapy into a structured, accessible digital format without losing its human core. The session presents first, yet unpublished, results from a randomized controlled trial evaluating a digital intervention based on Pain Reprocessing Therapy (PRT) and Emotional Awareness and Expression Therapy (EAET). Framed within the German healthcare system, the talk highlights how regulated, insurer-funded medical products can accelerate the paradigm shift toward brain-based pain treatment in routine care.
Learning Objectives:
At the conclusion of this session, attendees will be able to:
- sx describe how core elements of Pain Reprocessing Therapy (PRT) and Emotional Awareness and Expression Therapy (EAET) can be translated into a structured digital intervention without losing therapeutic depth
- explain how design choices (guidance, pacing, language, emotional safety) support engagement and clinical change in a digital mind–body program • summarize the role of randomized controlled trials in generating credible evidence for digital PRT/EAET interventions and interpret what early results can and cannot show
- outline the pathway in Germany by which a regulated digital medical product can become reimbursable for all insured patients (including requirements for evaluation and “positive care effects”)
- discuss how scientific evidence and real-world implementation can contribute to integration into routine care and, over time, inform clinical guidelines
Turning Neuroplastic Science into Standard Care: Outcomes and Utilization Impact From a Scalable Virtual Pain Recovery Program in a Health System Implementation by Chris Echterling, MD + Eric Anderson MD, PhD, MBA, FAANWorkshop Summary:
This session explores how Lin Health and WellSpan Health partnered to embed a scalable, insurance-reimbursable virtual neuroplastic care model across 100+ clinics. It will highlight real- world patient reported outcomes, healthcare utilization impact, and practical implementation lessons to help accelerate adoption of neuroplastic care as a standard of care.
Learning Objectives:
At the end of this session, attendees will have an enhanced knowledge of:
- The healthcare utilization impact and ROI of a virtual neuroplastic treatment delivered at scale.
- Key implementation strategies towards a successful partnership between a virtual provider of neuroplastic care and an integrated health system.
- Use of Collaborative Care billing codes and analysis of total cost of care to scale and sustain neuroplastic treatment.
- Attracting new patients to a health system (or clinics) solely for care from this partnership.
How Americans Think About Neuroplastic Symptoms by Matthew Goldberg, PhD
Workshop Summary:
Clinical trials demonstrate strong efficacy for neuroplastic recovery therapies, yet implementation remains limited. The primary barrier is public awareness, understanding, and implementation, not clinical effectiveness. This nationally representative study examines how Americans think about their symptoms, beliefs about whether those symptoms are neuroplastic, and what shapes their willingness to try neuroplastic recovery therapies. These findings will inform communication strategies that help more people recognize, trust, and access evidence-based treatment.
Learning Objectives:
- Understanding of when people attribute their symptoms to psychological causes.
- Explain key motivations and barriers influencing willingness to try neuroplastic recovery therapies.
- Identify priority audiences for public health communication strategies aimed at improving awareness and access.
Workshop Summary:
Learning Objectives:
